Campbell & Co Investment Adviser’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-61,780
Closed -$4.17M 1251
2025
Q3
$4.17M Buy
+61,780
New +$4.1M 0.32% 55
2025
Q2
Sell
-39,427
Closed -$2.44M 1269
2025
Q1
$2.44M Buy
39,427
+16,779
+74% +$1.11M 0.19% 146
2024
Q4
$1.63M Buy
+22,648
New +$1.77M 0.13% 231
2024
Q3
Sell
-14,392
Closed -$1.07M 1197
2024
Q2
$1.07M Buy
14,392
+4,385
+44% +$329K 0.09% 338
2024
Q1
$780K Sell
10,007
-61,523
-86% -$4.58M 0.07% 499
2023
Q4
$5.11M Buy
71,530
+63,637
+806% +$4.43M 0.46% 10
2023
Q3
$548K Buy
7,893
+265
+3% +$20K 0.07% 479
2023
Q2
$618K Sell
7,628
-3,089
-29% -$252K 0.11% 323
2023
Q1
$865K Buy
10,717
+1,890
+21% +$152K 0.16% 207
2022
Q4
$660K Buy
+8,827
New +$629K 0.16% 208
2022
Q2
Sell
-3,491
Closed -$268K 778
2022
Q1
$268K Buy
+3,491
New +$251K 0.07% 512
2021
Q4
Sell
-3,272
Closed -$242K 697
2021
Q3
$242K Buy
+3,272
New +$245K 0.08% 451
2021
Q1
Sell
-3,425
Closed -$249K 509
2020
Q4
$249K Buy
+3,425
New +$242K 0.15% 291
2019
Q4
Sell
-4,431
Closed -$224K 724
2019
Q3
$224K Sell
4,431
-577
-12% -$28.4K 0.08% 504
2019
Q2
$240K Sell
5,008
-6,957
-58% -$322K 0.11% 400
2019
Q1
$579K Buy
+11,965
New +$540K 0.28% 82
2018
Q2
Sell
-13,153
Closed -$491K 441
2018
Q1
$491K Buy
+13,153
New +$531K 0.41% 55
2017
Q4
Sell
-16,842
Closed -$618K 444
2017
Q3
$618K Buy
+16,842
New +$680K 0.5% 37
2016
Q3
Sell
-6,729
Closed -$233K 164
2016
Q2
$233K Buy
+6,729
New +$233K 1.18% 40

Other funds holding HOLX

Campbell & Co Investment Adviser's HOLX Position: Q4 2025 in Review

Campbell & Co Investment Adviser sold out of Hologic (HOLX) in Q4 2025, closing a stake of 61,780 shares — an estimated $4.17M sold.

Campbell & Co Investment Adviser first reported a position in HOLX in Q2 2016 and held it in 19 quarters. The position peaked at $5.11M in Q4 2023. 749 funds tracked by Wall St. Rank hold HOLX as of Q4 2025.

  • Campbell & Co Investment Adviser reported no remaining Hologic position as of Q4 2025 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 61,780 Hologic shares in Q4 2025, an estimated $4.17M.
  • Campbell & Co Investment Adviser first reported a position in Hologic in Q2 2016 and held it in 19 quarters.
  • Campbell & Co Investment Adviser's Hologic position peaked at $5.11M in Q4 2023.
  • 749 funds tracked by Wall St. Rank held Hologic as of Q4 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2025, filed 12 Feb 2026.